Blister parts included in the product exhibit
A single-layer sheet-based blister component with expandable legs and a sealable opening addresses the environmental impact of resin-heavy exhibitions by reducing resin use, enhancing stability, and facilitating leak detection.
Patent Information
- Application Number
- JP2019210280
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2019-11-21
- Publication Date
- 2025-02-05
- Estimated Expiration
- 2039-11-21
AI Technical Summary
Existing independent product exhibitions use a significant amount of synthetic resin, which is environmentally unfriendly, and there is a need for a design that reduces resin usage while maintaining functionality and stability.
The design incorporates a single-layer sheet-based blister component with expandable legs and a mount, featuring a space for product accommodation and a sealable opening, using reduced resin materials.
This design reduces synthetic resin usage, enhances stability, allows for easy product visibility, and provides a secondary space for leak detection, while maintaining design flexibility and environmental friendliness.
Smart Images

Figure 0007627083000001 
Figure 0007627083000002 
Figure 0007627083000003
Abstract
Description
[Technical field]
[0001] The present invention relates to a blister component contained in a free-standing display for displaying merchandise. [Background technology]
[0002] Conventionally, various display bodies are known in which products are packaged for display in stores. Typically, the product is contained in a blister container made of synthetic resin, which is then attached to a mount. The blister container is formed to be transparent, allowing the product to be seen from the outside. Meanwhile, the mount serves to advertise and decorate the product by printing letters, designs, etc. thereon. Such display bodies also serve to protect the product. Patent Document 1 discloses this type of display body, which is a free-standing display body that can be arranged on a display shelf. [Prior art documents] [Patent documents]
[0003] [Patent Document 1] JP 2017-149464 A Summary of the Invention [Problem to be solved by the invention]
[0004] As in Patent Document 1, in a freestanding display unit, generally, a printing area is secured on the front side of the mount, and legs are arranged on the back side of the mount in order to enhance design. The blister container in Patent Document 1 is constructed by connecting a sheet having legs protruding backward and another sheet having a cup-shaped storage section that bulges forward and stores a product along the bottom edge, and folding them back along the bottom edge so that they face each other, thus having a so-called shell pack structure. A mount is wrapped around such a blister container. However, a blister container with a shell pack structure like Patent Document 1 requires an increased amount of synthetic resin to be used.
[0005] An object of the present invention is to provide a blister component included in an environmentally friendly, free-standing product display with reduced synthetic resin usage, as well as a display and a packaged product including the same. [Means for solving the problem]
[0006] The blister part of a first aspect of the present invention is a blister part made of synthetic resin included in a free-standing display unit for displaying a product, and comprises a sheet-like base portion having a single-layer structure, a bulge portion which rises from the base portion, bulges forward and defines a space for containing the product inside, and legs which rise from the base portion near the lower part of the base portion and extend rearward so as to stand the display unit up.
[0007] The display according to a second aspect of the present invention comprises the blister part according to the first aspect, and a sheet-like mount having a front and a back surface, supported by the blister part, and having an opening formed therein. The base portion is disposed so as to face the back surface of the mount. The bulging portion is inserted into the opening from the back surface side of the mount, and bulges forward from the front surface of the mount.
[0008] An exhibit according to a third aspect of the present invention is the exhibit according to the second aspect, wherein the mount is in the form of a sheet with a single layer structure.
[0009] A fourth aspect of the present invention is an exhibit according to the second or third aspect, wherein the space defined by the bulging portion has an outlet for removing the product at the rear, and the exhibit further comprises a sheet-like sealing member attached to the back surface of the mount at least around the opening so as to close the outlet.
[0010] An exhibit according to a fifth aspect of the present invention is the exhibit according to any one of the second to fourth aspects, wherein the legs bulge rearward to define a space therein. The space defined by the legs is open at the front and is covered at the front by the mount.
[0011] A package product according to a sixth aspect of the present invention comprises the display article according to any one of the second to fifth aspects, and the product accommodated in the space defined by the bulge. Effect of the Invention
[0012] In accordance with the above-mentioned aspects, a blister part is provided having a base portion. A bulge portion defining a space for accommodating a product rises forward from the base portion, and a leg portion rises rearward near a lower portion of the base portion. The base portion is formed in a sheet-like shape having a single-layer structure. This reduces the amount of synthetic resin used, which is environmentally friendly. [Brief description of the drawings]
[0013] [Figure 1] 1 is an external perspective view of a blister component according to an embodiment of the present invention, and a display article and a packaged product including the blister component, viewed from the front left side. [Diagram 2] FIG. 2 is an external perspective view of the packaged product as viewed from the rear right side. [Diagram 3] Left side view of the packaged product. [Figure 4] 1 is a front view of a product (medicinal solution container) according to one embodiment of the present invention. [Diagram 5] FIG. [Figure 6] FIG. 4 is a front view of the drug solution container with the cover member open. [Figure 7] FIG. 13 is a left side view of the drug solution container with the clip attached. [Figure 8] Front view of the mount. [Figure 9] FIG. 2 is a perspective view of the blister part as viewed from the front left side. [Figure 10] FIG. 4 is an external perspective view of the blister part as viewed from the rear right side. [Figure 11] FIG. 3 is a diagram showing a state when the seal member is peeled off from the state shown in FIG. 2. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0014] Hereinafter, a blister part according to an embodiment of the present invention, and a display article and a packaged product including the blister part will be described with reference to the drawings.
[0015] <1. Overview of package product> 1 to 3 show external views of a blister component 3 according to this embodiment, as well as an exhibit 1 and a packaged product 100 including the blister component 3. Fig. 1 is a perspective view of the packaged product 100 seen from the front left side, Fig. 2 is a perspective view of the packaged product 100 seen from the rear right side, and Fig. 3 is a left side view of the packaged product 100. In addition, unless otherwise specified, in the description of the packaged product 100, the top, bottom, left, right, front (front face), and back (rear face, back surface) are defined as shown in Figs. 1 to 3.
[0016] The packaged product 100 includes a product 2 and a display unit 1 that packages the product 2 for display, and is displayed on a display shelf or the like installed in a storefront. The display unit 1 includes a sheet-like backing 4 and a blister part 3 made of synthetic resin that is fixed to the backing 4. The display unit 1 of this embodiment is a freestanding type, and legs 32 that protrude backward are arranged on the lower part of the blister part 3 so as to make the display unit 1 stand up. In addition, a bulging part 33 that bulges forward is arranged on the front of the blister part 3, and the bulging part 33 defines a space S1 (see FIG. 11) for storing the product 2 therein. In this embodiment, the blister part 3 is made of a transparent resin material. Therefore, the product 2 stored in the space S1 defined by the bulging part 33 is originally visible from the outside, but the product 2 is not shown in FIG. 1 and FIG. 3. The structure of the product 2 and the display unit 1 will be described in detail below.
[0017] <2. Configuration of each part> <2-1. Product (medicinal solution container)> In this embodiment, the exhibit 1 contains a liquid medicine container as a product 2. Hereinafter, the liquid medicine container may also be given the same reference symbol 2. Figs. 4 and 5 show a front view and a back view, respectively, of the liquid medicine container 2. The liquid medicine container 2 is a device that provides various effects of the liquid medicine to the surrounding space by volatilizing the liquid medicine into the surrounding space.
[0018] The medicinal liquid used here is not particularly limited in type, but is typically an aromatic, deodorant, or insect repellent, or a mixture thereof, and contains additives such as fragrance, deodorant component, insect repellent component, and colorant depending on the purpose of use. The solvent contained in the medicinal liquid is appropriately selected according to the type of additive used, and can be a hydrophilic solvent, a lipophilic solvent, or a mixture thereof. When the medicinal liquid contains a fragrance, it is preferable to contain at least a lipophilic solvent as a solvent in order to increase the fragrance intensity. As the hydrophilic solvent, for example, water or ethanol, or a mixture thereof can be used. As the lipophilic solvent, for example, glycol ether or isoparaffin solvent, or a mixture thereof can be used. In addition, the medicinal liquid may contain a dissolving agent to solubilize functional components such as fragrance, deodorant component, insect repellent component, and colorant.
[0019] As shown in Figs. 4 and 5, the liquid medicine container 2 has a container 20 containing the liquid medicine and a cover member 21 that covers the upper part of the container 20. The cover member 21 is configured to be openable and closable, and Fig. 6 shows a front view of the liquid medicine container 2 with the cover member 21 open. As shown in Fig. 6, the container 20 has a mouth portion 201 at its upper part, and a liquid absorbent wick 22 is inserted into the mouth portion 201 so as to extend vertically. The liquid absorbent wick 22 is a member that sucks up the liquid medicine. A cap 23 that covers the mouth portion 201 and the part of the liquid absorbent wick 22 that protrudes upward from the mouth portion 201 is detachably attached to the mouth portion 201. In Fig. 6, the positions of the mouth portion 201 and the liquid absorbent wick 22 that are covered by the container 20 and the cap 23 are indicated by dotted lines. In this embodiment, the container 20 is configured to be transparent, and the inside of the container 20 is normally visible from the outside. However, in FIGS. 4, 5, and 7, the inside of the container 20 is not shown.
[0020] When the cap 23 is attached to the mouth 201, the part of the absorbent wick 22 exposed upward from the mouth 201 is generally sealed by the cap 23 and is isolated from the external space. Therefore, in this state, the liquid medicine does not evaporate from the absorbent wick 22. Therefore, the cap 23 is attached to the container 20 when the liquid medicine container 2 is not in use, and is removed when the liquid medicine container 2 is in use. When the liquid medicine container 2 is in use, the above-mentioned cover member 21 is opened, the cap 23 is removed, and the cover member 21 is closed again. As shown in FIG. 5, a large number of volatilization ports 211 are formed on the back and upper surface of the cap 23. Therefore, when the cap 23 is removed, even if the cover member 21 is closed, the liquid medicine begins to volatilize from the absorbent wick 22 impregnated with the liquid medicine into the surrounding space through the above-mentioned volatilization ports 211, and the efficacy of the liquid medicine is exerted.
[0021] Although not limited thereto, the liquid medicine container 2 of this embodiment is for an automobile and is installed in the vehicle. More specifically, the liquid medicine container 2 is attached to a louver arranged at the air outlet of an air conditioner mounted on the vehicle. As a result, the liquid medicine container 2 can be efficiently distributed in the vehicle by being carried by the air flow blown out from the air conditioner outlet. In order to efficiently achieve this, the package product 100 contains a clip 24 shown in FIG. 7 as an accessory of the liquid medicine container 2 together with the liquid medicine container 2. The clip 24 is detachable from the above-mentioned cover member 21, and FIG. 7 shows a left side view of the liquid medicine container 2 in a state in which the clip 24 is attached to the cover member 21. More specifically, as shown in FIG. 5, an insertion opening 212 into which the base 241 of the clip 24 can be inserted is formed at approximately the center of the back surface of the cover member 21. The base 241 of the clip 24 and the insertion opening 212 of the cover member 21 are configured such that the clip 24 is firmly fixed to the cover member 21 when the former is inserted into the latter. The clip 24 has a pair of protruding pieces 242 and 243 that extend rearward from a base 241, and the liquid medicine container 2 is fixed near the air outlet by inserting a louver into the gap between these protruding pieces 242 and 243. In this state, the airflow blown out from the air outlet of the air conditioner enters the inside of the cover member 21 through the above-mentioned volatilization port 211, and is sent out from the inside of the cover member 21 to the surrounding space again through the volatilization port 211 with the liquid medicine on it.
[0022] <2-2.Exhibit> Next, the exhibit 1 will be described. The exhibit 1 has a blister part 3 made of synthetic resin and a mount 4 supported by the blister part 3. Fig. 8 is a front view of the mount 4 alone, and Figs. 9 and 10 are external perspective views of the blister part 3 as seen from the front left and rear right, respectively. The type of resin material constituting the blister part 3 is not particularly limited, but a preferred example is polyethylene terephthalate (PET). The blister part 3 of this embodiment is integrally formed from the same resin material.
[0023] The backing 4 is made of a single piece of cardboard and is formed in a flat sheet shape having a substantially rectangular shape. On the other hand, the blister part 3 has an uneven shape in the front-rear direction. More specifically, the blister part 3 has a flat sheet-like base part 31 and a bulging part 33 that rises forward from the vicinity of the upper part of the base part 31 and bulges forward. The base part 31 in this embodiment is formed in a sheet shape having a single-layer structure. As described above, the bulging part 33 defines the space S1 for accommodating the drug solution container 2 therein.
[0024] The blister part 3 further has a leg part 32 that rises from near the lower part of the base part 31 toward the rear and extends toward the rear. As shown in FIG. 2, when the blister part 3 is fixed to the mount 4, the leg part 32 is disposed at approximately the same height as the lower part of the mount 4, and constitutes the lower part of the exhibit 1 together with the lower part of the mount 4. Therefore, the leg part 32 extends rearward from the back surface of the mount 4 near the lower part of the mount 4, and the package product 100 can be firmly erected. In this embodiment, the leg part 32 also bulges out from the base part 31, similar to the bulging part 33, and a space S3 is formed inside. Therefore, the leg part 32 has a bulge and is configured to be large overall despite a small amount of synthetic resin, and as a result, the package product 100 can be more stably erected.
[0025] 2 and 10, the leg portion 32 of this embodiment has two long legs 321 and 321 that extend rearward from the vicinity of the left and right ends of the base portion 31. When the package product 100 is in an upright position, the mount 4 and the base portion 31 are inclined rearward as they move upward, and the rear ends of the long legs 321 and 321 come into contact with the display surface. As shown in FIG. 3, each of the long legs 321 is substantially trapezoidal in side view, and has a bottom surface portion 321a that extends horizontally, an upper surface portion 321b that slopes downward as it moves away from the base portion 31 rearward, and a rear surface portion 321c that extends in the vertical direction so as to connect the rear edges of the bottom surface portion 321a and the upper surface portion 321b. The bottom surface portion 321a and the top surface portion 321b each have a flat base surface, and on the base surface, ribs 322a and 322b extending in the front-rear direction at approximately the center in the left-right direction are further provided. The rear surface portion 321c also has a rib 322c extending in the up-down direction at approximately the center in the left-right direction, and the rib 322c on the rear surface portion 321c extends so as to connect the rib 322a on the bottom surface portion 321a and the rib 322b on the top surface portion 321b. In this embodiment, the cross section of the ribs 322a to 322c perpendicular to the longitudinal direction is semicircular, but it can be configured in various shapes such as a triangular shape or a rectangular shape. The above-mentioned ribs 322a to 322c improve the strength of the long legs 321 and 321 to which the weight of the packaged product 100 is added, and the packaged product 100 can be more stably erected.
[0026] The blister part 3 has a bulging portion 33 that bulges forward from the base surface portion 31, and another bulging portion 34 that also bulges forward from the base surface portion 31, as shown in Figs. 1 and 3. Hereinafter, these bulging portions 33 and 34 may be distinguished from each other by calling the former a first bulging portion and the latter a second bulging portion. The second bulging portion 34 defines a space S2 (see Fig. 11) below the space S1 defined by the first bulging portion 33 and communicating with the space S1. Hereinafter, these spaces S1 and S2 may be distinguished from each other by calling the former a first space and the latter a second space.
[0027] In this embodiment, the front-rear, left-right, and top-bottom widths of the liquid medicine container 2 are approximately equal to the front-rear, left-right, and top-bottom widths of the first space S1, respectively. The second space S2 communicating with the lower part of the first space S1 has a smaller front-rear thickness than the first space S1 as shown in Fig. 3, and also has a slightly narrower left-right width than the first space S1 as shown in Fig. 1. As a result of the above, the second space S2 is configured in a shape that prevents the liquid medicine container 2 contained in the first space S1 from entering, and the liquid medicine container 2 is generally unable to move within the space S1.
[0028] However, if the liquid medicine container 2 is opened, for example, by removing the cap 23 due to some reason such as vandalism at a store, the liquid medicine may leak from the liquid medicine container 2 depending on environmental conditions such as the surrounding temperature and humidity. If the lower part of the space in the blister part 3 in which the liquid medicine container 2 is accommodated is in contact with the liquid medicine container 2, the liquid medicine container 2 may block the view, and the liquid medicine may be left unnoticed and the surrounding environment in which the exhibit 1 is displayed may be polluted. In contrast, in this embodiment, when the liquid medicine container 2 is accommodated in the space S1, a space S2 is secured below the liquid medicine container 2. If the liquid medicine leaks from the liquid medicine container 2, the space S2 may function as a liquid reservoir for collecting the liquid medicine. Therefore, a user can easily confirm that the liquid medicine has leaked by visually checking the state of the second space S2.
[0029] As described above, the cross-sectional area A2 of the second space S2 is smaller than the cross-sectional area A1 of the first space S1. Here, the smaller the cross-sectional area A2 of the second space S2, the easier it is for the liquid level of the liquid medicine collected in the second space S2 to rise when the liquid medicine leaks from the liquid medicine container 2, making it easier to confirm that the liquid medicine is leaking. From this viewpoint, it is preferable that A2≦(3 / 4)·A1, it is more preferable that A2≦(2 / 3)·A1, and it is even more preferable that A2≦(1 / 2)·A1. It is also preferable that A2≧(1 / 10)·A1, it is more preferable that A2≧(1 / 8)·A1, and it is even more preferable that A2≧(1 / 5)·A1.
[0030] In this embodiment, the second space S2 accommodates a clip 24 as an accessory of the liquid medicine container 2. The presence of the clip 24 in the second space S2 contributes to further raising the liquid level of the liquid medicine collected in the second space S2 when the liquid medicine leaks from the liquid medicine container 2. Therefore, in this embodiment, it becomes easier to confirm that the liquid medicine is leaking.
[0031] As shown in Fig. 8, an opening 40 is formed in approximately the center of the backing sheet 4. The opening 40 is approximately rectangular and approximately matches the shape of the space formed by combining the first space S1 and the second space S2 in a front view. When the blister component 3 is attached to the backing sheet 4, the bulging portions 33 and 34 are inserted into the opening 40 from the back surface side of the backing sheet 4 and bulge forward from the front surface of the backing sheet 4. At this time, the base portion 31 of the blister component 3 is disposed so as to face and contact the back surface of the backing sheet 4.
[0032] When the bulging portions 33 and 34 of the blister part 3 are inserted into the opening 40 of the backing paper 4, the spaces S1 and S2 defined by the bulging portions 33 and 34 are open at the rear. The liquid medicine container 2 and the clip 24 are accommodated in the spaces S1 and S2, respectively, through the openings. The openings also serve as removal openings for removing the liquid medicine container 2 and the clip 24 from the spaces S1 and S2.
[0033] As shown in FIG. 2 and FIG. 11, the spaces S1 and S2 are closed by a sheet-like sealing member 5. FIG. 11 shows a state in which the sealing member 5 is peeled off from the state shown in FIG. 2. Note that the clip 24 is omitted in FIG. 11. More specifically, the sealing member 5 is attached to the back surface of the mount 4 around the opening 40 of the mount 4 so as to close the rear outlets of the spaces S1 and S2. At this time, in this embodiment, the sealing member 5 is also attached to the flange portion 311 included in the blister part 3. The flange portion 311 is a part of the base surface portion 31, and is a substantially square ring-shaped portion disposed on the upper portion of the base surface portion 31 so as to surround the outlets of the spaces S1 and S2. The flange portion 311 faces the back surface of the mount 4. The above-mentioned bulging portions 33 and 34 rise forward from the inner edge of the flange portion 311.
[0034] The seal member 5 is peelable from the back surface of the mount 4 and the flange portion 311, and in this embodiment, is particularly attached to the back surface of the mount 4 and the flange portion 311 in a resealable manner. The seal member 5 is a member in which an adhesive layer made of an adhesive is laminated in a predetermined area on one side of a sheet body. In this embodiment, the adhesive is applied along the outer periphery of one side of the approximately rectangular sheet body. The material of the sheet body included in the seal member 5 can be appropriately selected, and can be made of, for example, paper, cloth, or synthetic resin.
[0035] 2, the sealing member 5 has a central region 51 that has no adhesiveness, and a peripheral region 52 that surrounds the central region 51 and has the above-mentioned adhesive layer formed thereon and has adhesiveness. The peripheral region 52 faces the flange portion 311 and a region on the back surface of the mount 4 that is in the vicinity of the flange portion 311 and surrounds the flange portion 311, and is adhered to these. In this way, the sealing member 5 closes the spaces S1 and S2 in which the liquid medicine container 2 and the clip 24 are housed, and fixes the position of the blister part 3 relative to the mount 4 by sandwiching the flange portion 311 of the blister part 3 between the sealing member 5 and the mount 4. On the other hand, since no adhesive layer is formed in the central region 51 that covers the outlets of the spaces S1 and S2, no adhesive is attached to the liquid medicine container 2 and the clip 24.
[0036] Space S3 defined by leg portions 32 is open at the front (see FIG. 9). When bulging portions 33 and 34 are inserted into opening 40 to attach blister part 3 to mount paper 4, the opening of space S3 is covered at the front by mount paper 4. At this time, flange portion 312 comes into contact with the rear surface of mount paper 4. Note that flange portion 312 is a part of base portion 31, and is a substantially rectangular ring-shaped portion that is disposed at the lower portion of base portion 31 so as to surround the front opening of space S3.
[0037] As shown in Fig. 8, an inverted U-shaped notch 41 is formed in the lower part of the backing paper 4 at approximately the center in the left-right direction. Meanwhile, part 312a (see Figs. 1 and 9) of flange part 312 of blister part 3 that is sandwiched between long legs 321 and 321 functions as an insertion piece that is inserted from above into the notch 41. Then, by inserting part 312a into notch 41, leg part 32 is prevented from separating from the rear surface of backing paper 4, improving the ease of assembly of backing paper 4 and blister part 3. Furthermore, by inserting part 312a of blister part 3 into notch 41, it becomes easier to align the two when attaching blister part 3 to backing paper 4.
[0038] A substantially circular hole 42 is formed in the upper part of the mount 4 at approximately the center in the left-right direction. This allows the packaged product 100 to be displayed not only standing up on a display surface such as a display shelf, but also suspended by hanging the hole 42 on a hook of the display shelf or the like.
[0039] On the front side of the mount 4, characters, designs, etc. that advertise, explain, and decorate the liquid medicine container 2 are appropriately printed. In this embodiment, since the legs 32 are disposed on the back side of the mount 4, a sufficient printing area can be secured on the front side of the mount 4. Note that appropriate characters, designs, etc. can be printed on the back side of the mount 4 as well as the front side of the mount 4.
[0040] <3. Features> <3-1> In the blister part 3 of the above embodiment, the base surface part 31 is formed in a sheet shape with a single layer structure. Therefore, the amount of synthetic resin used is reduced, which reduces the cost and the environmental load. In addition, since the amount of synthetic resin used in the base surface part 31 is reduced, the thickness of the base surface part 31 as a whole is relatively thin, but the base surface part 31 is divided into a front upper part and a rear lower part, and the bulge part 33 and the leg part 32 are continuous with each other. Therefore, when the leg part 32 is placed on a display surface extending substantially horizontally, the package product 100 can maintain balance in the front-rear direction and the up-down direction, and the package product 100 can stand up stably. In addition, in the above embodiment, the mount 4, which is placed in a backward tilted position while facing the base surface part 31, also contributes to the stable standing of the package product 100.
[0041] <3-2> Conventionally, blister containers have often been attached to mounts by heat welding. However, depending on the type of ink or coating agent attached to the mount surface, poor welding may occur between the mount surface and the synthetic resin blister container, so the specifications of the mount surface have been limited. In this regard, in the above embodiment, the seal member 5 attached to the mount 4 closes the spaces S1 and S2 for accommodating the liquid medicine container 2 and the clip 24, and fixes the blister part 3 to the mount 4. Therefore, the exhibit 1 can be properly assembled without heat welding (or while reducing the number of places to be heat-welded). Also, in the above embodiment, the legs 32 are arranged on the back side of the mount 4, so the presence of the legs 32 does not limit the specifications of the front side of the mount 4. Therefore, the freedom of the configuration of the mount 4 is increased.
[0042] <3-3> In the above embodiment, a space (second space S2) for storing the liquid medicine is provided below the liquid medicine container 2 housed in the exhibit 1. Therefore, when the liquid medicine leaks from the liquid medicine container 2, the user can easily confirm this by visually checking the state of the second space S2.
[0043] <4. Modifications> Although one embodiment of the present invention has been described above, the present invention is not limited to the above embodiment, and various modifications are possible without departing from the spirit of the present invention. For example, the following modifications are possible. In addition, the gist of the following modifications can be combined as appropriate.
[0044] <4-1> In the above embodiment, the display 1 accommodates the liquid medicine container 2, but it may also accommodate other products.
[0045] <4-2> The accessories contained in the second space S2 can be appropriately selected depending on the type of the product 2. Alternatively, nothing needs to be contained in the space S2.
[0046] <4-3> In the above embodiment, the cut 41 is formed in the lower part of the backing 4, and the insertion piece (portion 312a) to be inserted into the cut 41 is formed near the leg portion 32 of the blister part 3. However, the insertion piece may be formed in the lower part of the backing 4, and a cut into which the insertion piece is inserted may be formed near the leg portion 32 of the blister part 3. [Explanation of symbols]
[0047] 100 Packaged Products 1 Exhibit 2. Product (medicinal solution container) 24 Clips (accessories) 3 Blister parts 31 Base part 311 Flange part 32 Legs 33 Bulge (first bulge) 34 Bulge (second bulge) 4. Mount 5. Sealing material 51 Central area 52 Surrounding Areas S1 space (first space) S2 space (second space)
Claims
1. A blister part made of synthetic resin included in a free-standing display for displaying a product, A sheet-like base portion having a single-layer structure; a bulging portion that rises from the base portion, bulges forward, and defines a space for accommodating the product therein; a leg portion including two long legs that rise from the base portion near the lower portion thereof and extend rearward from the left and right end portions of the base portion so as to stand up the exhibit, and an intermediate portion connected to the two long legs, and a single connected space is formed inside the two long legs and the intermediate portion; Equipped with the space defined by the bulge has an outlet at the rear for removing the product, The bulge and the leg are spaced apart from each other in the vertical direction. Blister parts.
2. A blister part according to claim 1 ; a sheet-like backing having a front surface and a back surface, supported by the blister part, and having an opening formed therein; Equipped with the base portion is disposed so as to face the back surface of the mount, the bulging portion is inserted into the opening from the back surface side of the mount and bulges forward from the front surface of the mount. Exhibit.
3. The mount is a sheet having a single layer structure. The exhibit according to claim 2.
4. The exhibit is: A sheet-like sealing member attached to the back surface of the mount at least around the opening so as to close the outlet. Further comprising:
4. The exhibit according to claim 2 or 3.
5. The space defined by the leg portion is open at the front and is covered at the front by the mount.
5. An exhibit according to any one of claims 2 to 4.
6. An exhibit according to any one of claims 2 to 5; The product accommodated in the space defined by the bulge portion; Equipped with Packaged products.
Citation Information
Patent Citations
Package
JP2016124547A
Commodity storage body
JP2017149464A
Blister display mount
JP2018002272A
Upright Standing Package
US20070029223A1
Standing packages and related methods of use
US20190248534A1